{"doi":"10.1007/3-7643-7305-9_12","title":"Second generation opioidergic compounds: clinical data","abstract":null,"journal":"Milestones in Drug Therapy MDT","year":null,"id":45142,"datarank":0.12004230625789325,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.016070229173901447,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.016070229173901447,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":1,"citers_with_citation_signal":1,"citers_with_endowment":1,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":211354,"name":"John David Sinclair","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"42257410","pmcid":null,"openalex_id":"https://openalex.org/W141273095","authors":[],"funders":[],"total_grants":0,"fwci":0.6582,"citation_percentile":0.69075369,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://doi.org/10.1007/3-7643-7305-9_12","host_type":"ebook platform"}],"fields_of_study":["Neuropeptides and Animal Physiology","Pharmacology and Obesity Treatment","Pharmacological Receptor Mechanisms and Effects","Chemistry","Medicine","Animals","Intravitreal Injections","Tetrodotoxin","Electroretinography","Dose-Response Relationship, Drug","Tomography, Optical Coherence","Retina","Evoked Potentials, Visual","Contrast Sensitivity","Male","Macaca mulatta","Female","Disease Models, Animal","Amblyopia","Sodium Channel Blockers"],"mesh_terms":["Animals","Intravitreal Injections","Tetrodotoxin","Electroretinography","Dose-Response Relationship, Drug","Tomography, Optical Coherence","Retina","Evoked Potentials, Visual","Contrast Sensitivity","Male","Macaca mulatta","Female","Disease Models, Animal","Amblyopia","Sodium Channel Blockers"],"keywords":["Nalmefene","Naltrexone","Opioidergic","Opioid antagonist","(+)-Naloxone","Opioid","Pharmacology","Opioid receptor","Narcotic antagonist","Chemistry","Antagonist","Medicine","Internal medicine","Receptor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-02T03:18:46.717130Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}